Gray matter concentration and effective connectivity changes in Alzheimer’s disease: a longitudinal structural MRI study

2010 ◽  
Vol 53 (10) ◽  
pp. 733-748 ◽  
Author(s):  
Xingfeng Li ◽  
Damien Coyle ◽  
Liam Maguire ◽  
David R Watson ◽  
Thomas M McGinnity
2008 ◽  
Vol 4 ◽  
pp. T307-T307
Author(s):  
Philipp A. Thomann ◽  
Vasco Dos Santos ◽  
Marco Essig ◽  
Johannes Schröder

2008 ◽  
Vol 42 (14) ◽  
pp. 1198-1202 ◽  
Author(s):  
Philipp A. Thomann ◽  
Christine Schläfer ◽  
Ulrich Seidl ◽  
Vasco Dos Santos ◽  
Marco Essig ◽  
...  

Author(s):  
Lenka Krajcovicova ◽  
Patricia Klobusiakova ◽  
Irena Rektorova

Abstract Purpose of Review We summarize structural (s)MRI findings of gray matter (GM) atrophy related to cognitive impairment in Alzheimer’s disease (AD) and Parkinson’s disease (PD) in light of new analytical approaches and recent longitudinal studies results. Recent Findings The hippocampus-to-cortex ratio seems to be the best sMRI biomarker to discriminate between various AD subtypes, following the spatial distribution of tau pathology, and predict rate of cognitive decline. PD is clinically far more variable than AD, with heterogeneous underlying brain pathology. Novel multivariate approaches have been used to describe patterns of early subcortical and cortical changes that relate to more malignant courses of PD. Summary New emerging analytical approaches that combine structural MRI data with clinical and other biomarker outcomes hold promise for detecting specific GM changes in the early stages of PD and preclinical AD that may predict mild cognitive impairment and dementia conversion.


2007 ◽  
Vol 49 (12) ◽  
pp. 967-976 ◽  
Author(s):  
Giorgos Karas ◽  
Philip Scheltens ◽  
Serge Rombouts ◽  
Ronald van Schijndel ◽  
Martin Klein ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (10) ◽  
pp. e26113 ◽  
Author(s):  
Eini Niskanen ◽  
Mervi Könönen ◽  
Sara Määttä ◽  
Merja Hallikainen ◽  
Miia Kivipelto ◽  
...  

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Malo Gaubert ◽  
Catharina Lange ◽  
Antoine Garnier-Crussard ◽  
Theresa Köbe ◽  
Salma Bougacha ◽  
...  

Abstract Background White matter hyperintensities (WMH) are frequently found in Alzheimer’s disease (AD). Commonly considered as a marker of cerebrovascular disease, regional WMH may be related to pathological hallmarks of AD, including beta-amyloid (Aβ) plaques and neurodegeneration. The aim of this study was to examine the regional distribution of WMH associated with Aβ burden, glucose hypometabolism, and gray matter volume reduction. Methods In a total of 155 participants (IMAP+ cohort) across the cognitive continuum from normal cognition to AD dementia, FLAIR MRI, AV45-PET, FDG-PET, and T1 MRI were acquired. WMH were automatically segmented from FLAIR images. Mean levels of neocortical Aβ deposition (AV45-PET), temporo-parietal glucose metabolism (FDG-PET), and medial-temporal gray matter volume (GMV) were extracted from processed images using established AD meta-signature templates. Associations between AD brain biomarkers and WMH, as assessed in region-of-interest and voxel-wise, were examined, adjusting for age, sex, education, and systolic blood pressure. Results There were no significant associations between global Aβ burden and region-specific WMH. Voxel-wise WMH in the splenium of the corpus callosum correlated with greater Aβ deposition at a more liberal threshold. Region- and voxel-based WMH in the posterior corpus callosum, along with parietal, occipital, and frontal areas, were associated with lower temporo-parietal glucose metabolism. Similarly, lower medial-temporal GMV correlated with WMH in the posterior corpus callosum in addition to parietal, occipital, and fontal areas. Conclusions This study demonstrates that local white matter damage is correlated with multimodal brain biomarkers of AD. Our results highlight modality-specific topographic patterns of WMH, which converged in the posterior white matter. Overall, these cross-sectional findings corroborate associations of regional WMH with AD-typical Aß deposition and neurodegeneration.


Sign in / Sign up

Export Citation Format

Share Document